Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
762 studies found for:    "Esophageal Neoplasms"
Show Display Options
Rank Status Study
1 Completed Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Cancer of the Esophagus;   Esophagus Cancer;   Esophageal Neoplasm;   Cancer of Esophagus
Interventions: Drug: Irinotecan (drug);   Drug: Taxotere (drug);   Procedure: Radiotherapy (procedure);   Procedure: Esophagectomy (procedure)
2 Recruiting Phase III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
Conditions: Esophageal Neoplasms;   Esophageal Cancer
Interventions: Radiation: Adjuvant Chemoradiation;   Radiation: Adjuvant Radiation;   Drug: Paclitaxel;   Drug: Cisplatin
3 Recruiting Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
Conditions: Esophageal Neoplasm;   Esophageal Cancer TNM Staging Primary Tumor (T) T2;   Esophageal Cancer TNM Staging Primary Tumor (T) T3;   Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0;   Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Intervention: Radiation: Prophylactic postoperative radiation therapy
4 Completed Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
5 Completed Outcomes After Esophageal Cancer Surgery
Conditions: Esophageal Neoplasm;   Esophageal Disease
Intervention: Procedure: Esophagectomy
6 Terminated Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell;   Adenocarcinoma;   Esophageal Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: [18-F] Fluorodeoxyglucose (FDG);   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin
7 Unknown  Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
8 Completed Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: Pronase;   Drug: Control
9 Terminated Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
Conditions: Barrett Esophagus;   Esophageal Neoplasms;   Deglutition Disorders;   GERD;   Neoplasm
Interventions: Device: CSA System (CryoSpray AblationTM System);   Device: CryoSpray Ablation
10 Terminated A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Procedure: Esophagectomy
11 Recruiting Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Ferumoxytol
12 Terminated Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: CD40 Ligand Gene (AdcuCD40L)
13 Terminated Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: AdcuCD40L
14 Active, not recruiting Early Detection of Esophageal Cancer
Conditions: Esophageal Neoplasms;   Stomach Neoplasms;   Endoscopy, Gastrointestinal;   Digestive System Endoscopic Surgical Procedures;   Cytology
15 Completed
Has Results
Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial
Condition: Esophageal Neoplasm
Interventions: Other: Restrictive group;   Other: Liberal group
16 Completed PET-CT Based Radiotherapy in Esophageal Cancer Patients
Condition: Esophageal Neoplasms
17 Recruiting Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Condition: Esophageal Neoplasms
Interventions: Other: Preoperative treatment of chemotherapy and radiation;   Other: Postoperative treatment of chemotherapy and radiation
18 Recruiting Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer
Conditions: Surgical Procedures;   Minimally Invasive;   Operative;   Esophageal Neoplasms;   Cancer of Esophagus;   Esophagectomy
Interventions: Procedure: Ivor Lewis;   Procedure: Tri-incision
19 Completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Recurrent Esophageal Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage III Esophageal Cancer;   Stage IV Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
20 Active, not recruiting Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Stomach;   Squamous Cell Carcinoma of the Esophagus;   Stage II Esophageal Cancer;   Stage II Gastric Cancer;   Stage III Esophageal Cancer;   Stage III Gastric Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: oxaliplatin;   Drug: fluorouracil;   Radiation: radiation therapy;   Procedure: conventional surgery;   Other: immunohistochemistry staining method;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: laboratory biomarker analysis;   Genetic: gene expression analysis;   Radiation: fludeoxyglucose F 18

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years